Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.

Infections with the hepatitis E virus ... "Using high-resolution X-ray structure analyses, we were able to visualize the precise binding of the antibodies to the virus for the first time." ...

Catching HBV early can make a world of difference. Medical professionals typically use blood tests that check for signs of ...

Currently, there is no feline vaccine for the hepatitis B virus, and the hepatitis B vaccine for humans is highly toxic to ...

While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the body's defences are unable to ...

The following is a summary of “Chronic hepatitis B virus infection increases the risk of kidney disease while antiviral ...

The hepatitis B virus infects liver cells and is not to be confused with other types of hepatitis viruses, including the better known hepatitis A and C. The virus is spread by bodily fluids ...

Scientists from the Institut Pasteur, in collaboration with Kumamoto University in Japan, have assessed a new rapid ...

Aligos Therapeutics is a clinical-stage biotechnology company focused on improving patient outcomes through best-in-class ...